Cellectar Biosciences, Inc. (CLRB): Total Assets
$14.98M
As of 2025-12-31
$36.64M
As of 2026-06-30
-11.5%
3-year compound annual growth
-23.9%
5-year compound annual growth
+7.0%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $14.98M | -41.2% | 2026-03-04, Balance as of period end |
| 2024-12-31 | $25.47M | +111.0% | 2026-03-04, Balance as of period end |
| 2023-12-31 | $12.08M | n/a | 2025-03-13, Balance as of period end |
| 2023-09-30 | $21.55M | n/a | 2024-10-29, Balance as of period end |
| 2023-06-30 | $6.51M | n/a | 2024-10-29, Balance as of period end |
| 2023-03-31 | $14.84M | n/a | 2024-10-29, Balance as of period end |
| 2022-12-31 | $21.59M | n/a | 2024-10-29, Balance as of period end |
| 2022-09-30 | $19.32M | n/a | 2024-10-29, Balance as of period end |
| 2022-06-30 | $25.89M | n/a | 2024-10-29, Balance as of period end |
| 2022-03-31 | $31.99M | n/a | 2024-10-29, Balance as of period end |
| 2021-12-31 | $37.20M | -36.6% | 2023-03-09, Balance as of period end |
| 2020-12-31 | $58.66M | +378.8% | 2022-03-21, Balance as of period end |
| 2019-12-31 | $12.25M | -18.6% | 2021-03-02, Balance as of period end |
| 2018-12-31 | $15.05M | +17.0% | 2020-03-09, Balance as of period end |
| 2017-12-31 | $12.87M | -16.0% | 2019-02-26, Balance as of period end |
| 2016-12-31 | $15.32M | +101.7% | 2018-03-21, Balance as of period end |
| 2015-12-31 | $7.60M | -43.4% | 2017-03-15, Balance as of period end |
| 2014-12-31 | $13.42M | +96.9% | 2016-10-20, Balance as of period end |
| 2013-12-31 | $6.82M | -40.6% | 2015-05-20, Balance as of period end |
| 2012-12-31 | $11.48M | +8.7% | 2014-03-19, Balance as of period end |
| 2011-12-31 | $10.56M | +120.0% | 2013-03-28, Balance as of period end |
| 2010-12-31 | $4.80M | n/a | 2012-03-09, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Cellectar Biosciences, Inc. (CLRB) | 2025-12-31 | $14.98M | -41.2% |
| Cingulate Inc. (CING) | 2025-12-31 | $15.07M | +1.4% |
| Synlogic, Inc. (SYBX) | 2025-12-31 | $15.45M | -22.1% |
| Biovie Inc. (BIVI) | 2026-06-30 | $14.25M | -33.9% |
| Reviva Pharmaceuticals Holdings, Inc. (RVPH) | 2025-12-31 | $15.92M | +2.7% |
| Aprea Therapeutics, Inc. (APRE) | 2025-12-31 | $15.93M | -33.6% |
| Exicure, Inc. (XCUR) | 2025-12-31 | $14.04M | -6.7% |
| Actuate Therapeutics, Inc. (ACTU) | 2025-12-31 | $14.04M | +50.6% |
| CytoDyn Inc. (CYDY) | 2026-05-31 | $13.97M | -22.6% |
Compare CLRB, CING, SYBX, BIVI side by side · Screen every company in Pharmaceutical Preparations ↗